We are live on ! Find out more
AVBP icon

ArriVent BioPharma
AVBP

106 hedge funds and large institutions have $712M invested in ArriVent BioPharma in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 19

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

7% more funds holding

Funds holding: 99 → 106 (+7)

3% less capital invested

Capital invested by funds: $732M → $712M (-$19.7M)

3.21% less ownership

Funds ownership: 98.29% → 95.07% (-3.2%)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

76% less call options, than puts

Call options by funds: $424K | Put options by funds: $1.75M

Holders
106
Holders Change
+7
Holders Change %
+7.07%
% of All Funds
1.39%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
18
Increased
46
Reduced
19
Closed
11
Calls
$424K
Puts
$1.75M
Net Calls
-$1.33M
Net Calls Change
-$1.33M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$26.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10.7M
3
IAM
Infinitum Asset Management
Florida
+$8.84M
4
UBS Group
UBS Group
Switzerland
+$8.08M
5
Morgan Stanley
Morgan Stanley
New York
+$5.71M

Top Sellers

Rank Fund Capital Flow
1
HLAM
Hidden Lake Asset Management
New York
-$5.75M
2
Squarepoint
Squarepoint
New York
-$1.49M
3
WAM
Weiss Asset Management
Massachusetts
-$1.17M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$814K
5
Citadel Advisors
Citadel Advisors
Florida
-$733K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.27M +$480K +24,412 +12%
Marshall Wace
27
Marshall Wace
United Kingdom
$3.33M +$3.54M +180,223 New
Barclays
28
Barclays
United Kingdom
$2.4M +$250K +12,723 +11%
Squarepoint
29
Squarepoint
New York
$2.37M -$1.49M -76,048 -37%
BGM
30
Burkehill Global Management
New York
$1.84M +$1.96M +100,000 New
AFM
31
Anson Funds Management
Texas
$1.84M +$1.96M +99,887 New
Two Sigma Investments
32
Two Sigma Investments
New York
$1.69M +$1.8M +91,718 New
Wellington Management Group
33
Wellington Management Group
Massachusetts
$1.51M +$303K +15,417 +23%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.17M +$88.5K +4,505 +8%
MAP
35
Moody Aldrich Partners
Massachusetts
$1.1M -$238K -12,121 -17%
N
36
Nuveen
North Carolina
$879K – – –
Bank of America
37
Bank of America
North Carolina
$848K +$299K +15,230 +50%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$808K +$206K +10,500 +32%
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$780K +$780K +39,697 +1,544%
A
40
AlphaQuest
New York
$765K +$814K +41,449 New
SAM
41
Sectoral Asset Management
Quebec, Canada
$724K +$71.8K +3,655 +10%
SG Americas Securities
42
SG Americas Securities
New York
$682K +$186K +9,469 +34%
ECM
43
ExodusPoint Capital Management
New York
$667K -$225K -11,449 -24%
Swiss National Bank
44
Swiss National Bank
Switzerland
$655K +$179K +9,100 +34%
Rafferty Asset Management
45
Rafferty Asset Management
New York
$634K +$366K +18,612 +118%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$624K -$2.97K -151 -0.4%
CI
47
Corient IA
Florida
$618K +$658K +33,500 New
Corient Private Wealth
48
Corient Private Wealth
Florida
$618K +$658K +33,500 New
AllianceBernstein
49
AllianceBernstein
Tennessee
$520K – – –
Walleye Capital
50
Walleye Capital
New York
$512K +$360K +18,314 +194%
1
2
3 4 5

AVBP Hedge Fund Activity: Q3 2025 in Review

106 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in ArriVent BioPharma (AVBP) for Q3 2025, worth a combined $712M — down 2.7% from $732M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AVBP positions and 11 closed out — a net gain of 7 holders — while 46 added to existing stakes and 19 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $26.5M. The largest seller was Hidden Lake Asset Management, cutting an estimated $5.75M.

  • 106 institutional investors held ArriVent BioPharma (AVBP) as of Q3 2025, up from 99 in Q2 2025.
  • Funds reported $712M of ArriVent BioPharma stock for Q3 2025, down 2.7% quarter-over-quarter.
  • 18 funds opened new ArriVent BioPharma positions in Q3 2025 and 11 closed out, a net change of +7 holders.
  • The largest ArriVent BioPharma buyer in Q3 2025 was Fidelity Investments, an estimated $26.5M added.
  • The largest ArriVent BioPharma seller in Q3 2025 was Hidden Lake Asset Management, an estimated $5.75M sold.

Based on aggregated 13F filings for Q3 2025.